Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SRZNSurrozen, Inc./DE

Nasdaq · CIK 0001824893
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts279

Identity from submissions API

NameSurrozen, Inc./DE
CIK0001824893
TickersSRZN
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN301374889
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-475-2820
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Consonance-HFW Acquisition Corp. (2020-09-18T00:00:00.000Z → 2021-08-11T00:00:00.000Z)
Business address
171 OYSTER POINT BLVD
SUITE 400
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
171 OYSTER POINT BLVD
SUITE 400
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

513 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-470421 005-91867 261579935 34 19509
2026-11-18 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-467393 005-91867 261571904 34 33366
2026-11-18 S-3 S-3 0001193125-26-467212 333-300141 261571144 33 2062378 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-464080 005-91867 261563486 34 14905
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001873545-26-000012 005-91867 261562137 34 14737
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-008110 005-91867 261560763 34 12371
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127781 005-91867 261556517 34 20525
2026-11-16 424B5 424B5 0001193125-26-462212 333-294542 261555650 33 883769
2026-11-16 8-K 8-K 1.01,9.01 0001193125-26-462191 001-39635 261555596 34 623249 1 1
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005058 005-91867 261555149 34 15026
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127256 005-91867 261554266 34 19700
2026-11-13 FWP FWP 0001193125-26-459340 333-294542 261549077 34 18128
2026-11-09 10-Q 10-Q 0001193125-26-453790 001-39635 261536798 34 11620502 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001193125-26-453641 001-39635 261536222 34 468360 1 1
2026-11-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-451852 005-91867 261532033 34 32036
2026-10-22 4 4 0001193125-26-429058 36768
2026-10-22 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-429027 005-91867 261479289 34 35220
2026-10-22 4 4 0001193125-26-429026 25934
2026-10-20 8-K 8-K 2.02,3.02,9.01 0001193125-26-426828 001-39635 261473539 34 199441 1 1
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-107661 005-91867 261447963 34 12899
2026-10-02 8-K 8-K 8.01 0001193125-26-411298 001-39635 261433452 34 150150 1 1
2026-10-01 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000044 005-91867 261432237 34 15174
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-003732 005-91867 261281544 34 12042
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-090021 005-91867 261281187 34 12859
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-096754 005-91867 261278359 34 17843
2026-08-11 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001873545-26-000005 005-91867 261263587 34 14860
2026-08-07 25-NSE xslF25X02/primary_doc.xml 0001354457-26-000770 001-39635 261255260 34 3169
2026-08-06 10-Q 10-Q 0001193125-26-338120 001-39635 261249509 34 12047429 1 1
2026-08-06 8-K 8-K 2.02 0001193125-26-338068 001-39635 261249302 34 558343 1 1
2026-07-24 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-316577 005-91867 261202682 34 18828
2026-07-24 4 4 0001193125-26-316570 14461
2026-06-16 4 4 0001193125-26-272796 5021
2026-06-16 4 4 0001193125-26-272780 6391
2026-06-16 4 4 0001193125-26-272765 5001
2026-06-16 4 4 0001193125-26-272754 5194
2026-05-19 4 4 0001193125-26-230953 5643
2026-05-18 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-227857 005-91867 26990743 34 37750
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062678 005-91867 26988800 34 11283
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000056 005-91867 26988641 34 19385
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226874 005-91867 26988202 34 17949
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001873545-26-000003 005-91867 26987138 34 14790
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-057691 005-91867 26986696 34 12747
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-061993 005-91867 26983310 34 17496
2026-05-14 4 4 0001193125-26-224286 5512
2026-05-14 4 4 0001193125-26-224244 5502
2026-05-14 4 4 0001193125-26-224157 5524
2026-05-14 4 4 0001193125-26-224145 5526
2026-05-14 4 4 0001193125-26-224131 5486
2026-05-14 4 4 0001193125-26-224117 5484
2026-05-14 8-K 8-K 5.07 0001193125-26-224037 001-39635 26979035 34 220126 1 1
2026-05-06 10-Q 10-Q 0001193125-26-209179 001-39635 26949180 34 10143237 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001193125-26-208999 001-39635 26948620 34 430211 1 1
2026-05-05 4 4 0001193125-26-206695 10442
2026-05-05 4 4 0001193125-26-206679 9052
2026-05-05 4 4 0001193125-26-206658 9249
2026-04-23 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002357 005-91867 26889465 34 18933
2026-04-01 4 4 0001193125-26-138292 6240
2026-04-01 ARS ARS 0001193125-26-137997 001-39635 26828657 34 1671597
2026-04-01 DEFA14A DEFA14A 0001193125-26-137989 001-39635 26828630 34 409826
2026-04-01 DEF 14A DEF 14A 0001193125-26-137976 001-39635 26828592 34 13341993 1 1
2026-03-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001000 333-294542 26816639 33 1895
2026-03-30 424B5 424B5 0001193125-26-132378 333-294542 26815369 33 319440
2026-03-27 CORRESP filename1.htm 0001193125-26-129011 11749
2026-03-27 UPLOAD filename1.pdf 0000000000-26-003144 333-294542 40250
2026-03-25 4 4 0001193125-26-124608 15784
2026-03-23 S-8 S-8 0001193125-26-120018 333-294543 26783393 33 472546 1 1
2026-03-23 S-3 S-3 0001193125-26-120016 333-294542 26783385 33 1808310 1 1
2026-03-23 10-K 10-K 0001193125-26-119818 001-39635 26782629 34 15086911 1 1
2026-03-23 8-K 8-K 2.02,9.01 0001193125-26-119757 001-39635 26782437 34 447309 1 1
2026-03-16 4 4 0001193125-26-108827 18498
2026-02-18 4 4 0001193125-26-057665 7904
2026-02-18 4 4 0001193125-26-057657 7881
2026-02-18 4 4 0001193125-26-057652 8073
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-26-000897 005-91867 26642931 34 18125
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-26-000057 005-91867 26642738 34 15247
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015991 005-91867 26637489 34 17217
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-26-000093 005-91867 26634411 34 18647
2026-02-13 4 4 0001193125-26-051452 15430
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-010924 005-91867 26603319 34 19335
2026-02-03 4 4 0001193125-26-036301 18484
2026-02-02 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-033663 005-91867 26587992 34 318819
2026-01-30 8-K 8-K 5.02 0001193125-26-031798 001-39635 26583445 34 180572 1 1
2026-01-28 3 3 0001193125-26-027558 67672
2026-01-26 4 4 0001193125-26-022713 5480
2026-01-22 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-019817 005-91867 26552876 34 164288
2026-01-20 4 4 0001193125-26-016991 25945
2026-01-20 4 4 0001193125-26-016980 15544
2026-01-15 4 4 0001193125-26-014101 12449
2026-01-15 4 4 0001193125-26-014100 22850
2026-01-08 4 4 0001193125-26-007857 19752
2026-01-08 4 4 0001193125-26-007847 9351
2026-01-06 4 4 0001193125-26-005094 10313
2026-01-06 4 4 0001193125-26-005092 8923
2025-12-16 4 4 0001193125-25-321315 6254
2025-12-16 4 4 0001193125-25-321306 4864
2025-12-16 4 4 0001193125-25-321305 5016
2025-12-08 4 4 0001193125-25-311404 12465
2025-12-08 4 4 0001193125-25-311384 21420
2025-12-02 4 4 0001193125-25-305738 9604
2025-11-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-114631 005-91867 251503416 34 18660
2025-11-17 4 4 0001193125-25-284943 18310
2025-11-13 4 4 0001193125-25-280240 5570
2025-11-13 3 3 0001193125-25-280204 18972
2025-11-07 10-Q 10-Q 0001193125-25-272422 001-39635 251463008 34 11154222 1 1
2025-11-07 8-K 8-K 2.02,5.02 0001193125-25-272363 001-39635 251462774 34 514465 1 1
2025-10-17 8-K 8-K 1.02 0001193125-25-242518 001-39635 251400997 34 187136 1 1
2025-08-29 8-K 8-K 1.01,9.01 0000950170-25-112253 001-39635 251281742 34 815582 1 1
2025-08-29 424B5 424B5 0000950170-25-112251 333-287434 251281715 33 622982
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078697 005-91867 251220152 34 11106
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078228 005-91867 251215389 34 16898
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000938206-25-000031 005-91867 251214376 34 6175
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000493 005-91867 251211638 34 18858
2025-08-08 S-8 S-8 0000950170-25-105876 333-289432 251198768 33 896819 1 1
2025-08-08 10-Q 10-Q 0000950170-25-105847 001-39635 251198573 34 11380370 1 1
2025-08-08 8-K 8-K 2.02,9.01 0000950170-25-105839 001-39635 251198538 34 491544 1 1
2025-06-16 4 PRIMARY DOCUMENT 0001593968-25-000787 5860
2025-06-16 4 PRIMARY DOCUMENT 0001593968-25-000786 4929
2025-06-16 4 PRIMARY DOCUMENT 0001593968-25-000785 5096
2025-05-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001737 333-287434 25984042 33 1895
2025-05-21 CORRESP filename1.htm 0000950170-25-075814 11552
2025-05-21 UPLOAD filename1.pdf 0000000000-25-005443 333-287434 40223
2025-05-20 S-3 S-3 0000950170-25-075238 333-287434 25969272 33 1962264
2025-05-15 4 PRIMARY DOCUMENT 0001593968-25-000613 5450
2025-05-15 4 PRIMARY DOCUMENT 0001593968-25-000612 5488
2025-05-15 4 PRIMARY DOCUMENT 0001593968-25-000611 5488
2025-05-15 4 PRIMARY DOCUMENT 0001593968-25-000610 5476
2025-05-15 4 PRIMARY DOCUMENT 0001593968-25-000609 5482
2025-05-15 4 PRIMARY DOCUMENT 0001593968-25-000608 5466
2025-05-15 4 PRIMARY DOCUMENT 0001593968-25-000607 5448
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-013196 005-91867 25954975 34 20222
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049543 005-91867 25954539 34 7944
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072728 005-91867 25954061 34 11065
2025-05-15 8-K 8-K 5.07 0000950170-25-072696 001-39635 25953750 34 209647 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049168 005-91867 25950415 34 16468
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000938206-25-000024 005-91867 25948738 34 6652
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000333 005-91867 25945675 34 19634
2025-05-09 10-Q 10-Q 0000950170-25-068046 001-39635 25930657 34 9870477 1 1
2025-05-09 8-K 8-K 2.02,9.01 0000950170-25-068011 001-39635 25930436 34 433152 1 1
2025-05-05 4 PRIMARY DOCUMENT 0001593968-25-000593 8052
2025-05-05 4 PRIMARY DOCUMENT 0001593968-25-000592 8023
2025-05-05 4 PRIMARY DOCUMENT 0001593968-25-000591 8190
2025-05-01 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001372 333-286703 25905351 33 1895
2025-05-01 424B5 424B5 0000950170-25-061898 333-286703 25903733 33 331331
2025-04-29 CORRESP filename1.htm 0000950170-25-060257 12295
2025-04-29 UPLOAD filename1.pdf 0000000000-25-004525 333-286703 40209
2025-04-24 424B5 424B5 0000950170-25-058037 333-278800 25867433 33 72584
2025-04-23 S-3 S-3 0000950170-25-057413 333-286703 25861750 33 678313
2025-04-08 D xslFormDX01/primary_doc.xml 06b 0001824893-25-000001 021-543181 25821145 33 15346
2025-04-02 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-009669 005-91867 25805600 34 36158
2025-04-02 ARS ARS 0000950170-25-049368 001-39635 25804956 34 3452127
2025-04-02 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-009648 005-91867 25804927 34 18273
2025-04-02 DEFA14A DEFA14A 0000950170-25-049361 001-39635 25804898 34 377376
2025-04-02 DEF 14A DEF 14A 0000950170-25-049352 001-39635 25804779 34 1600173
2025-03-31 S-8 S-8 0000950170-25-047810 333-286269 25793946 33 264200
2025-03-31 10-K 10-K 0000950170-25-047712 001-39635 25793355 34 14266693 1 1
2025-03-31 8-K 8-K 2.02,9.01 0000950170-25-047702 001-39635 25793230 34 424687 1 1
2025-03-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-047680 005-91867 25792992 34 146123
2025-03-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-047114 005-91867 25788461 34 47826
2025-03-28 4 4 0000950170-25-047110 5322
2025-03-28 3 3 0000950170-25-047106 24216
2025-03-28 4 4 0000950170-25-047104 65862
2025-03-28 8-K 8-K 1.01,3.02,5.02,9.01 0000950170-25-046769 001-39635 25786039 34 1480177 1 1
2025-03-25 4 PRIMARY DOCUMENT 0001593968-25-000414 17200
2025-03-25 4 PRIMARY DOCUMENT 0001593968-25-000413 17367
2025-03-24 8-K 8-K 7.01,9.01 0001193125-25-061361 001-39635 25764305 34 12142489 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014209 005-91867 25629783 34 11818
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001168 005-91867 25629294 34 10976
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021227 005-91867 25628916 34 24406
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-013831 005-91867 25626004 34 16384
2025-01-22 4 PRIMARY DOCUMENT 0001593968-25-000112 5769
2025-01-22 4 PRIMARY DOCUMENT 0001593968-25-000111 5631
2025-01-22 4 PRIMARY DOCUMENT 0001593968-25-000110 5599
2025-01-06 4 PRIMARY DOCUMENT 0001593968-25-000043 6919
2025-01-06 4 PRIMARY DOCUMENT 0001593968-25-000041 6813
2024-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-119182 005-91867 241463842 34 7550
2024-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-119170 005-91867 241463841 34 11950
2024-11-14 SC 13G/A alyeska-srzn093024a1.htm 0001172661-24-005261 005-91867 241463349 34 106434
2024-11-13 SC 13G/A srzn13ga1.htm 0000935836-24-000673 005-91867 241455912 34 62077
2024-11-08 SC 13G/A SURROZEN GSCO FILING Q3 2024 0000769993-24-000380 005-91867 241438785 34 24237
2024-11-06 10-Q 10-Q 0000950170-24-122318 001-39635 241431086 34 9638604 1 1
2024-11-06 8-K 8-K 2.02 0000950170-24-121856 001-39635 241429397 34 431439 1 1
2024-11-01 SC 13G SC 13G 0001104659-24-113385 005-91867 241418148 34 89692
2024-10-02 8-K 8-K 1.01,9.01 0000950170-24-111493 001-39635 241347831 34 296074 1 1
2024-08-12 10-Q 10-Q 0000950170-24-095443 001-39635 241196951 34 8446140 1 1
2024-08-12 8-K 8-K 2.02 0000950170-24-095414 001-39635 241196822 34 409150 1 1
2024-07-01 8-K 8-K 5.02 0000950170-24-079690 001-39635 241091275 34 186657 1 1
2024-06-18 4 PRIMARY DOCUMENT 0001593968-24-000869 4969
2024-06-18 4 PRIMARY DOCUMENT 0001593968-24-000868 4936
2024-06-18 4 PRIMARY DOCUMENT 0001593968-24-000867 5103
2024-06-07 8-K 8-K 5.07 0000950170-24-070741 001-39635 241030151 34 201901 1 1
2024-06-06 4 PRIMARY DOCUMENT 0001593968-24-000834 5473
2024-06-06 4 PRIMARY DOCUMENT 0001593968-24-000833 5489
2024-06-06 4 PRIMARY DOCUMENT 0001593968-24-000832 5483
2024-06-06 4 PRIMARY DOCUMENT 0001593968-24-000831 5471
2024-06-06 4 PRIMARY DOCUMENT 0001593968-24-000830 5495
2024-06-06 4 PRIMARY DOCUMENT 0001593968-24-000828 5495
2024-06-06 4 PRIMARY DOCUMENT 0001593968-24-000827 5457
2024-06-06 4 PRIMARY DOCUMENT 0001593968-24-000826 5455
2024-05-08 10-Q 10-Q 0000950170-24-055706 001-39635 24926379 34 7332235 1 1
2024-05-08 8-K 8-K 2.02 0000950170-24-055667 001-39635 24926179 34 367574 1 1
2024-05-02 4 PRIMARY DOCUMENT 0001593968-24-000680 5626
2024-05-02 4 PRIMARY DOCUMENT 0001593968-24-000679 5594
2024-05-02 4 PRIMARY DOCUMENT 0001593968-24-000678 5761
2024-04-26 4 PRIMARY DOCUMENT 0001593968-24-000622 7908
2024-04-26 4 PRIMARY DOCUMENT 0001593968-24-000621 5765
2024-04-26 4 PRIMARY DOCUMENT 0001593968-24-000620 7876
2024-04-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-25 16:00:00 9999999995-24-001131 333-278800 24878376 33 1902
2024-04-25 424B5 424B5 0000950170-24-048371 333-278800 24876805 33 247347
2024-04-23 CORRESP filename1.htm 0000950170-24-047059 11028
2024-04-23 ARS ARS 0000950170-24-046959 001-39635 24865203 34 3455918
2024-04-23 DEFA14A DEFA14A 0000950170-24-046937 001-39635 24865163 34 348033
2024-04-23 DEF 14A DEF 14A 0000950170-24-046931 001-39635 24865142 34 1343144
2024-04-23 UPLOAD filename1.pdf 0000000000-24-004472 333-278800 40464
2024-04-19 SC 13G surrozen13g.htm 0000935836-24-000364 005-91867 24858262 34 68306
2024-04-19 D xslFormDX01/primary_doc.xml 06b 0001824893-24-000002 021-511096 24857503 33 14402
2024-04-18 S-3 S-3 0000950170-24-045612 333-278800 24854804 33 507063
2024-04-17 4/A 4/A 0000950170-24-045118 12173
2024-04-17 4/A 4/A 0000950170-24-045110 8450
2024-04-17 SC 13D/A SC 13D/A 0001193125-24-099085 005-91867 24851129 34 85665
2024-04-15 SC 13G SC 13G 0001104659-24-047308 005-91867 24845190 34 93073
2024-04-10 S-8 S-8 0000950170-24-043414 333-278608 24836429 33 223130
2024-04-10 10-K 10-K 0000950170-24-043399 001-39635 24836291 34 13940320 1 1
2024-04-08 SC 13D/A SC 13D/A 0001193125-24-089766 005-91867 24830706 34 101041
2024-04-08 4 PRIMARY DOCUMENT 0001593968-24-000563 14157
2024-04-08 4 PRIMARY DOCUMENT 0001593968-24-000562 14324
2024-04-08 4 4 0000950170-24-042636 27170
2024-04-08 4 4 0000950170-24-042633 30865
2024-04-02 8-K 8-K 1.01,3.02,9.01 0000950170-24-040337 001-39635 24815439 34 1774707 1 1
2024-04-02 NT 10-K NT 10-K 0000950170-24-040190 001-39635 24814563 34 194773
2024-04-01 8-K 8-K 7.01,9.01 0000950170-24-038902 001-39635 24805781 34 11487522 1 1
2024-02-14 SC 13G alyeska-srzn123123.htm 0001172661-24-001199 005-91867 24635754 34 106936
2024-02-09 SC 13G SURROZEN.txt 0000769993-24-000132 005-91867 24616996 34 23578
2024-02-07 4 PRIMARY DOCUMENT 0001593968-24-000209 5721
2024-02-07 SC 13G/A srzn13g020724.htm 0001616824-24-000036 005-91867 24603491 34 55334
2024-02-07 424B3 424B3 0000950170-24-011938 333-259496 24602035 33 66536
2024-02-07 8-K 8-K 5.02 0000950170-24-011936 001-39635 24602011 34 187408 1 1
2024-01-22 424B3 424B3 0000950170-24-006150 333-259496 24549880 33 72062
2024-01-18 8-K 8-K 8.01 0000950170-24-005198 001-39635 24540182 34 195586 1 1
2023-12-18 4 PRIMARY DOCUMENT 0001593968-23-001519 5297
2023-12-18 4 PRIMARY DOCUMENT 0001593968-23-001518 5261
2023-12-18 4 PRIMARY DOCUMENT 0001593968-23-001517 5416
2023-12-13 424B3 424B3 0000950170-23-070107 333-259496 231484968 33 80159
2023-12-13 8-K 8-K 5.03 0000950170-23-070103 001-39635 231484901 34 228837 1 1
2023-12-11 424B3 424B3 0000950170-23-069408 333-259496 231478244 33 77492
2023-12-11 8-K 8-K 5.07,8.01 0000950170-23-069405 001-39635 231478199 34 203186 1 1
2023-11-08 424B3 424B3 0000950170-23-061182 333-259496 231388311 33 2557925
2023-11-08 10-Q 10-Q 0000950170-23-061150 001-39635 231388140 34 9579962 1 1
2023-11-08 8-K 8-K 2.02 0000950170-23-061101 001-39635 231387896 34 475313 1 1
2023-10-24 DEFA14A DEFA14A 0000950170-23-054873 001-39635 231342943 34 572469
2023-10-24 DEF 14A DEF 14A 0000950170-23-054865 001-39635 231342886 34 1151546
2023-10-13 PRE 14A PRE 14A 0000950170-23-053336 001-39635 231325532 34 865544
2023-10-13 8-K 8-K 5.03 0000950170-23-053312 001-39635 231325274 34 503682 1 1
2023-08-23 3 PRIMARY DOCUMENT 0001593968-23-001250 12528
2023-08-09 424B3 424B3 0000950170-23-040686 333-259496 231155827 33 2740140
2023-08-09 10-Q 10-Q 0000950170-23-040648 001-39635 231155589 34 10011973 1 1
2023-08-09 8-K 8-K 2.02,9.01 0000950170-23-040611 001-39635 231155389 34 514644 1 1
2023-07-19 8-K 8-K 5.02,9.01 0000950170-23-033527 001-39635 231096898 34 312243 1 1
2023-07-05 8-K 8-K 3.01 0000950170-23-031664 001-39635 231069702 34 211255 1 1
2023-06-20 4 PRIMARY DOCUMENT 0001593968-23-001021 5240
2023-06-20 4 PRIMARY DOCUMENT 0001593968-23-001020 5080
2023-06-20 4 PRIMARY DOCUMENT 0001593968-23-001019 5125
2023-05-22 8-K 8-K 5.07,9.01 0000950170-23-023389 001-39635 23943689 34 240114 1 1
2023-05-22 4 4 0000950170-23-023326 5296
2023-05-19 4 PRIMARY DOCUMENT 0001593968-23-000844 5179
2023-05-19 4 PRIMARY DOCUMENT 0001593968-23-000843 5326
2023-05-19 4 PRIMARY DOCUMENT 0001593968-23-000842 5336
2023-05-19 4 PRIMARY DOCUMENT 0001593968-23-000841 5324
2023-05-19 4 PRIMARY DOCUMENT 0001593968-23-000839 5348
2023-05-19 4 PRIMARY DOCUMENT 0001593968-23-000838 5348
2023-05-19 4 PRIMARY DOCUMENT 0001593968-23-000837 5290
2023-05-10 424B3 424B3 0000950170-23-020629 333-259496 23907317 33 2485317
2023-05-10 10-Q 10-Q 0000950170-23-020618 001-39635 23907182 34 9541892 1 1
2023-05-10 8-K 8-K 2.02,9.01 0000950170-23-020519 001-39635 23906536 34 461206 1 1
2023-04-07 424B3 424B3 0000950170-23-012216 333-259496 23809293 33 96007
2023-04-07 424B3 424B3 0001193125-23-095384 333-259496 23809268 33 5267734
2023-04-06 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-086961,2023-04-06 9999999995-23-000841 333-259496 23807696 33 1866
2023-04-06 ARS ARS 0000950170-23-012112 001-39635 23807202 34 5329127
2023-04-06 DEFA14A DEFA14A 0000950170-23-012110 001-39635 23807184 34 384545
2023-04-06 DEF 14A DEF 14A 0000950170-23-012109 001-39635 23807154 34 1829608
2023-04-06 424B3 424B3 0001193125-23-094167 333-263923 23807094 33 422108
2023-04-05 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-088258,2023-04-05 9999999995-23-000828 333-263923 23804291 33 1866
2023-04-05 3 PRIMARY DOCUMENT 0001593968-23-000584 4457
2023-04-05 8-K 8-K 5.02 0000950170-23-011915 001-39635 23802811 34 215644 1 1
2023-03-31 POS AM POS AM 0001193125-23-088258 333-263923 23788779 33 500321
2023-03-31 424B5 424B5 0001193125-23-086966 333-268745 23783599 33 53525
2023-03-31 POS AM POS AM 0001193125-23-086961 333-259496 23783595 33 14667280 1 1
2023-03-31 S-8 S-8 0000950170-23-011127 333-271017 23783127 33 333396
2023-03-31 10-K 10-K 0000950170-23-011118 001-39635 23783088 34 19934031 1 1
2023-03-23 424B3 424B3 0000950170-23-009329 333-263923 23754533 33 113521
2023-03-23 424B3 424B3 0000950170-23-009327 333-259496 23754525 33 124837
2023-03-23 8-K 8-K 8.01 0000950170-23-009326 001-39635 23754517 34 248083 1 1
2023-03-22 8-K 8-K 2.02,9.01 0000950170-23-009202 001-39635 23753315 34 513260 1 1
2023-03-02 4 PRIMARY DOCUMENT 0001593968-23-000390 5647
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021481 005-91867 23628452 34 118579
2023-02-13 SC 13D/A SC 13D/A 0001193125-23-035858 005-91867 23618759 34 86430
2023-02-02 4 PRIMARY DOCUMENT 0001593968-23-000265 5535
2023-02-02 4 PRIMARY DOCUMENT 0001593968-23-000264 5493
2023-02-02 SC 13G NONE 0001567619-23-001711 005-91867 23581245 34 66904
2023-02-02 SC 13G/A SC13G/A 0001140361-23-004120 005-91867 23580437 34 72741
2023-01-05 424B3 424B3 0000950170-23-000266 333-259496 23512485 33 109527
2023-01-05 424B3 424B3 0000950170-23-000264 333-263923 23512472 33 99500
2023-01-05 8-K 8-K 3.01 0000950170-23-000250 001-39635 23511893 34 211589 1 1
2022-12-21 424B5 424B5 0001193125-22-309496 333-268745 221476446 33 293404
2022-12-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-12-19 16:00:00 9999999995-22-003585 333-268745 221472767 33 1854
2022-12-19 4 PRIMARY DOCUMENT 0001593968-22-001750 4899
2022-12-19 4 PRIMARY DOCUMENT 0001593968-22-001749 5053
2022-12-19 4 PRIMARY DOCUMENT 0001593968-22-001746 4889
2022-12-19 4 PRIMARY DOCUMENT 0001593968-22-001745 4939
2022-12-15 CORRESP filename1.htm 0001193125-22-305911 8856
2022-12-15 UPLOAD filename1.pdf 0000000000-22-013502 40367
2022-12-15 SC 13D/A SC 13D/A 0001193125-22-305454 005-91867 221463833 34 166597
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038571 35625
2022-12-15 424B3 424B3 0000950170-22-026580 333-263923 221463821 33 117853
2022-12-15 424B3 424B3 0000950170-22-026579 333-259496 221463820 33 128103
2022-12-15 8-K 8-K 8.01 0000950170-22-026578 001-39635 221463819 34 208279 1 1
2022-12-09 S-3 S-3 0001193125-22-301907 333-268745 221455752 33 1577703
2022-11-16 8-K 8-K 2.02,9.01 0000950170-22-025228 001-39635 221392701 34 512180 1 1
2022-11-15 424B3 424B3 0000950170-22-025141 333-263923 221389275 33 4637650
2022-11-15 424B3 424B3 0000950170-22-025140 333-259496 221389274 33 4647809
2022-11-14 10-Q 10-Q 0000950170-22-025096 001-39635 221387975 34 12263668 1 1
2022-10-13 4 PRIMARY DOCUMENT 0001593968-22-001522 20423
2022-10-13 4 PRIMARY DOCUMENT 0001593968-22-001521 20433
2022-10-12 4 PRIMARY DOCUMENT 0001593968-22-001520 14135
2022-10-12 4 PRIMARY DOCUMENT 0001593968-22-001519 20426
2022-10-06 8-K 8-K 1.01 0000950170-22-019332 001-39635 221297137 34 218321 1 1
2022-08-25 424B3 424B3 0000950170-22-017739 333-263923 221192644 33 2646995
2022-08-23 424B3 424B3 0000950170-22-017699 333-259496 221188281 33 2656551
2022-08-11 10-Q 10-Q 0000950170-22-016889 001-39635 221156146 34 9537600 1 1
2022-08-11 8-K 8-K 2.02,9.01 0000950170-22-016735 001-39635 221154707 34 442773 1 1
2022-06-14 8-K 8-K 5.07,9.01 0000950170-22-011611 001-39635 221014229 34 228577 1 1
2022-06-09 4 PRIMARY DOCUMENT 0001593968-22-001114 5423
2022-06-09 4 PRIMARY DOCUMENT 0001593968-22-001113 5440
2022-06-09 4 PRIMARY DOCUMENT 0001593968-22-001112 5440
2022-06-09 4 PRIMARY DOCUMENT 0001593968-22-001111 5426
2022-06-09 4 PRIMARY DOCUMENT 0001593968-22-001110 5428
2022-06-09 4 PRIMARY DOCUMENT 0001593968-22-001109 5445
2022-06-09 4 PRIMARY DOCUMENT 0001593968-22-001108 5400
2022-05-12 424B3 424B3 0000950170-22-009431 333-263923 22915307 33 2120434
2022-05-12 424B3 424B3 0000950170-22-009429 333-259496 22915304 33 2129591
2022-05-11 10-Q 10-Q 0000950170-22-009343 001-39635 22913924 34 8746491 1 1
2022-05-11 8-K 8-K 2.02,9.01 0000950170-22-009148 001-39635 22912158 34 392392 1 1
2022-05-10 SC 13G SCHEDULE 13G 0001014108-22-000097 005-91867 22906390 34 59507
2022-04-28 DEFA14A DEFA14A 0001140361-22-016636 001-39635 22867878 34 1487061
2022-04-28 DEF 14A DEF14A 0001140361-22-016630 001-39635 22867821 34 2332555
2022-04-05 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-04-05 16:00:00 9999999995-22-000831 333-263923 22809302 33 1853
2022-04-05 424B3 424B3 0001193125-22-096256 333-263923 22807649 33 4872498
2022-04-01 CORRESP filename1.htm 0001193125-22-093589 8114
2022-04-01 UPLOAD filename1.pdf 0000000000-22-003549 40331
2022-03-31 424B3 424B3 0001193125-22-090279 333-259496 22788756 33 4958720
2022-03-29 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-087091,2022-03-29 9999999995-22-000751 333-259496 22783091 33 1866
2022-03-29 S-8 S-8 0001193125-22-087116 333-263924 22777263 33 101150
2022-03-29 S-1 S-1 0001193125-22-087100 333-263923 22777226 33 14888149 1 1
2022-03-29 POS AM POS AM 0001193125-22-087091 333-259496 22777213 33 14983844 1 1
2022-03-28 10-K 10-K 0000950170-22-004787 001-39635 22775699 34 14947968 1 1
2022-03-24 8-K 8-K 2.02,5.08,9.01 0000950170-22-004485 001-39635 22764771 34 432098 1 1
2022-03-03 4 PRIMARY DOCUMENT 0001593968-22-000639 5506
2022-03-03 4 PRIMARY DOCUMENT 0001593968-22-000638 5653
2022-03-03 4 PRIMARY DOCUMENT 0001593968-22-000637 5548
2022-03-03 4 PRIMARY DOCUMENT 0001593968-22-000636 5491
2022-02-24 424B3 424B3 0000950170-22-001994 333-259496 22671741 33 634286
2022-02-24 8-K 8-K 1.01,3.02,9.01 0000950170-22-001988 001-39635 22671593 34 919956 1 1
2022-02-14 SC 13G/A bridger-chfw123121a1.htm 0001172661-22-000873 005-91867 22634579 34 92073
2022-02-14 SC 13G/A chfw20211231.htm 0001076809-22-000099 005-91867 22633383 34 65400
2022-02-14 SC 13G SCHEDULE 13G 0001104659-22-022840 005-91867 22632163 34 110005
2022-02-11 SC 13G/A e621310_sc13ga-surrozen.htm 0001193805-22-000260 005-91867 22621301 34 99262
2022-01-27 SC 13G/A SC 13G/A 0001140361-22-002779 005-91867 22559416 34 58877
2022-01-10 424B3 424B3 0000950170-22-000194 333-259496 22519845 33 86756
2022-01-10 8-K 8-K 8.01 0000950170-22-000190 001-39635 22519824 34 211714 1 1
2021-11-16 424B3 424B3 0000950170-21-004679 333-259496 211415678 33 3168886
2021-11-15 10-Q 10-Q 0000950170-21-004618 001-39635 211411419 34 10851877 1 1
2021-11-15 8-K 8-K 2.02,9.01 0000950170-21-004608 001-39635 211411032 34 483769 1 1
2021-11-10 424B3 424B3 0001193125-21-324706 333-259496 211393555 33 5491781
2021-11-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-11-09 16:00:00 9999999995-21-004262 333-259496 211394217 33 1854
2021-11-08 CORRESP filename1.htm 0001193125-21-323165 6456
2021-11-08 S-1/A S-1/A 0001193125-21-323016 333-259496 211387873 33 5661593
2021-11-08 S-8 S-8 0001193125-21-322353 333-260858 211386573 33 489052
2021-09-29 SC 13D/A form_sc13da-surrozen.htm 0001011438-21-000225 005-91867 211290007 34 94776
2021-09-27 UPLOAD filename1.pdf 0000000000-21-011725 40357
2021-09-13 S-1 REGISTRATION STATEMENT ON FORM S-1 0001193125-21-271554 333-259496 211250292 33 20277995 1 1
2021-08-23 SC 13D SC 13D 0001193125-21-254000 005-91867 211197071 34 108671
2021-08-20 3/A FORM 3/A SUBMISSION 0001209191-21-052852 8351
2021-08-20 3/A FORM 3/A SUBMISSION 0001209191-21-052851 7101
2021-08-20 3/A FORM 3/A SUBMISSION 0001209191-21-052850 5877
2021-08-20 3/A FORM 3/A SUBMISSION 0001209191-21-052848 7933
2021-08-18 SC 13D/A form_sc13da-surrozen.htm 0001011438-21-000200 005-91867 211186594 34 120382
2021-08-17 8-K 8-K 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.05,5.06 0001193125-21-249342 001-39635 211184157 34 2230945 1 1
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051728 13313
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051727 12995
2021-08-16 4 FORM 4 SUBMISSION 0001209191-21-051726 5781
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051724 11230
2021-08-16 4 FORM 4 SUBMISSION 0001209191-21-051723 5617
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051719 10679
2021-08-16 4 FORM 4 SUBMISSION 0001209191-21-051718 5668
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051717 8825
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051715 8046
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051714 8036
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051713 8047
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051712 8054
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051711 8049
2021-08-16 3 FORM 3 SUBMISSION 0001209191-21-051710 8014

Latest XBRL company facts

One latest value per concept from companyfacts (279 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 19.06M 2026-11-05 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
dei EntityNumberOfEmployees Entity Number of Employees Employees 59 2022-10-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
dei EntityPublicFloat Entity Public Float USD 59.70M 2025-06-30 2025 FY 10-K 2026-03-23 0001193125-26-119818
ffd NetFeeAmt NetFeeAmt USD 32,727 2026-11-18 S-3 2026-11-18 0001193125-26-467212
ffd TtlFeeAmt TtlFeeAmt USD 32,727 2026-11-18 S-3 2026-11-18 0001193125-26-467212
ffd TtlOfferingAmt TtlOfferingAmt USD 376.17M 2026-11-18 S-3 2026-11-18 0001193125-26-467212
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-18 S-3 2026-11-18 0001193125-26-467212
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 652,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 5.00M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338120
us-gaap AccruedEmployeeBenefitsCurrentAndNoncurrent Accrued Employee Benefits USD 3.35M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 10.91M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 10.91M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 804,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 8.38M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2023-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 398.71M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 21.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqm 6.48M 2020-01-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 100,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap Assets Assets USD 109.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AssetsCurrent Assets, Current USD 102.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 92.00M 2020-12-01 2021 Q2 10-Q 2021-08-09 0001193125-21-239469
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 92.03M 2021-06-30 2021 Q2 10-Q 2021-08-09 0001193125-21-239469
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 98,000 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 17,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 31.13M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2023-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 51.15M 2022-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 21.66M 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 400,000 2021-08-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap BusinessCombinationConsiderationTransferredLiabilitiesIncurred Business Combination, Consideration Transferred, Liabilities Incurred USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 208,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 100.35M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 27.30M 2024-03-31 2024 Q1 10-Q 2024-05-08 0000950170-24-055706
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 100.99M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 11.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2021-06-30 2021 Q2 10-Q 2021-08-09 0001193125-21-239469
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 172.5 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 11.10M 2024-04-30 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 434,000 2020-12-31 2020 FY 10-K/A 2021-05-14 0001193125-21-161965
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 6.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 100,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 12.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 12.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -63.56M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 16.74M 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 51.39M 2022-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent Debt Securities, Available-for-sale, Amortized Cost, Noncurrent USD 21.75M 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 27.52M 2022-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 242,000 2022-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Investments 7 2022-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 50,689 2020-09-30 2020 Q3 10-Q/A 2021-01-05 0001104659-21-000654
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 69.40M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.68M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 41.05M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 4,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 612,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 2.25M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 692,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 939,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 67.72M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.68M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 167,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap DerivativeFairValueHedgeIncludedInEffectivenessGainLoss Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss) USD -111.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap DerivativeLiabilities Derivative Liability USD 270.12M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -18.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.23 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009343
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -18.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.031 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.023 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.011 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.07 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 7.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 32.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 59.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -7.89M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 326,000 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 400,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105847
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ImpairmentChargeOnReclassifiedAssets Impairment Charge on Reclassified Assets USD 100,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 300,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -241.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -242.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -49,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares -2.21 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 7.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -50.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 239,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 10,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -5.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -16.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -76,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 5.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338120
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -208,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -802,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 385,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 428,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 790,341 2020-08-21 2020-12-31 2020 FY 10-K/A 2021-05-14 0001193125-21-161965
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338120
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 30,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 108,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 2.20M 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.66M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.80M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 857,000 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 857,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.55M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.46M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 581,000 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272422
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.02M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap Liabilities Liabilities USD 444.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 109.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap LiabilitiesCurrent Liabilities, Current USD 13.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 271.21M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap LongTermInvestments Long-term Investments USD 25.25M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap MarketableSecurities Marketable Securities USD 104.30M 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009343
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2023-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 35.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -166,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -24.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -207.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -77.33M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338120
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -77.33M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338120
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -328,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 650 2020-09-30 2020 Q3 10-Q/A 2021-01-05 0001104659-21-000654
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338120
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 2.11M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001193125-21-239469
us-gaap OperatingExpenses Operating Expenses USD 48.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -38.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 6.64M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.79M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.083 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 322,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OtherAssets Other Assets USD 925,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 431,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 241,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent Other Employee-related Liabilities USD 3,000 2023-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap OtherExpenses Other Expenses USD 5.10M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -59.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 671,000 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 1.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061150
us-gaap ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic Participating Securities, Distributed and Undistributed Earnings (Loss), Basic USD -7.57M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105847
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap PaymentsForRestructuring Payments for Restructuring USD 44,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016889
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 280,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 166,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 526,805 2021-06-30 2021 Q2 10-Q 2021-08-09 0001193125-21-239469
us-gaap PrepaidInsurance Prepaid Insurance USD 469,000 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap PrepaidRent Prepaid Rent USD 290,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025096
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 50.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 4.34M 2020-08-21 2020-12-31 2020 FY 10-K/A 2021-05-14 0001193125-21-161965
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 29.80M 2026-10-01 2026-10-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 147,753 2020-08-21 2020-12-31 2020 FY 10-K/A 2021-05-14 0001193125-21-161965
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 183,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.10M 2026-10-01 2026-10-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -207.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 8.81M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 432,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ReinsuranceRetentionPolicyAmountRetained Reinsurance Retention Policy, Amount Retained USD 1.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 147,753 2020-08-21 2020-12-31 2020 FY 10-K/A 2021-05-14 0001193125-21-161965
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 28.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap RestrictedCash Restricted Cash USD 635,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 100.99M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 635,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap RestructuringCharges Restructuring Charges USD 2.75M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -734.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap Revenues Revenues USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 300,000 2021-09-01 2021-09-30 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 50.00M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016889
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 5.70M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 4,961 2020-08-21 2020-09-30 2020 Q3 10-Q/A 2021-01-05 0001104659-21-000654
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 600,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.712 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.009 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 11.63M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 751,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 18.03 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 780,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 28.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.99M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 132.15 2022-10-01 2022-10-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 18.35 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 4.26M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 1.70M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 6.23 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 19.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased USD/shares 2.73 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 12.8 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 38.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 16.11 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 24.81 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 15.5 2024-04-30 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap ShortTermInvestments Short-term Investments USD 49.07M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004618
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -335.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.176 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 42,451 2016-03-01 2016-03-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 12.02M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 114.47M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 214,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 26.86M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 2.93M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 91,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 700,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 400,000 2022-12-12 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 78.04M 2021-06-30 2021 Q2 10-Q 2021-08-09 0001193125-21-239469
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004787
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338120
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338120
us-gaap UndistributedEarningsLossAvailableToCommonShareholdersBasic Undistributed Earnings (Loss) Available to Common Shareholders, Basic USD -7.57M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105847
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 925,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2021-06-30 2021 Q2 10-Q 2021-08-09 0001193125-21-239469
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047712
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 15.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119818
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 115,000 2023-12-31 2023 FY 10-K 2024-04-10 0000950170-24-043399
us-gaap WarrantsAndRightsOutstandingMeasurementInput Warrants and Rights Outstanding, Measurement Input pure 0.008 2021-08-11 2022 FY 10-K 2023-03-31 0000950170-23-011118
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 11,465 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 34,863 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0000950170-22-009343
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 11,465 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453790

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →